# Artia Global Partners LP 13F holdings Q2 2026: $542 million

Artia Global Partners LP reported $542 million in 13F securities across 48 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Abivax SA at $68.8 million, 12.7% of the reported value. Since Q1 2026 it opened 8 new positions and exited 10.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $541,855,576
- Positions: 48
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1937964
- Form 13F file number: 028-23071
- CRD number: 322091
- Business address: 1 Se 3rd Avenue Ste 2120, Miami, FL 33131
- SEC filing: [0001937964-26-000008](https://www.sec.gov/Archives/edgar/data/1937964/000193796426000008/0001937964-26-000008-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/artia-global-partners-lp-322091)

## Top 25 holdings by value

The largest of 48 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 516,447 | $68.8 million | -84,300 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 589,052 | $62.8 million | -39,660 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 2,210,852 | $41.2 million | +197,250 |
| [Brightspring Health SVCS Inc](https://specstream.ai/data/institutional-holders/brightspring-health-svcs-inc-10950a106) | COM | 517,315 | $36.1 million | +463,515 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 185,390 | $34.7 million | +60,400 |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 29,739 | $27.6 million | No change |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 448,964 | $23.5 million | New |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 339,033 | $19.3 million | +268,333 |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 98,376 | $18.7 million | +3,000 |
| [Newamsterdam Pharma Company](https://specstream.ai/data/institutional-holders/newamsterdam-pharma-company-n62509109) | ORDINARY SHARES | 503,936 | $17.1 million | No change |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 162,990 | $15.9 million | No change |
| SPDR Series Trust | ST STR SP BIOT (put) | 100,000 | $15.8 million | New |
| [Quest Diagnostics Inc](https://specstream.ai/data/institutional-holders/quest-diagnostics-inc-74834l100) | COM | 65,122 | $13.8 million | +24,305 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 144,376 | $11.4 million | No change |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 767,098 | $11 million | No change |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 278,546 | $7.8 million | -46,500 |
| [Viking Therapeutics Inc](https://specstream.ai/data/institutional-holders/viking-therapeutics-inc-92686j106) | COM | 180,731 | $7.1 million | No change |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 59,316 | $6.2 million | +43,740 |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 70,700 | $6 million | +54,400 |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 46,700 | $6 million | No change |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 138,508 | $5.8 million | No change |
| [Johnson & Johnson](https://specstream.ai/data/institutional-holders/johnson-johnson-478160104) | COM | 22,600 | $5.7 million | No change |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 38,100 | $5.7 million | New |
| [Absci Corporation](https://specstream.ai/data/institutional-holders/absci-corporation-00091e109) | COM | 464,444 | $5.4 million | New |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 96,285 | $5.3 million | No change |

## New positions in Q2 2026

8 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 448,964 | $23.5 million |
| SPDR Series Trust | ST STR SP BIOT (put) | 100,000 | $15.8 million |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 38,100 | $5.7 million |
| [Absci Corporation](https://specstream.ai/data/institutional-holders/absci-corporation-00091e109) | COM | 464,444 | $5.4 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 17,740 | $4.7 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 33,400 | $3.2 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 383,200 | $839,208 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 4,000 | $355,120 |

## Positions exited in Q2 2026

10 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Insmed Inc | COM PAR $.01 (put) | 279,700 | $45.7 million |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 38,220 | $35.2 million |
| Moderna Inc | COM (call) | 200,000 | $10.2 million |
| Terns Pharmaceuticals Inc | COM | 104,800 | $5.5 million |
| Ascendis Pharma A/S | SPONSORED ADR | 17,740 | $4.1 million |
| [Abbvie Inc](https://specstream.ai/data/institutional-holders/abbvie-inc-00287y109) | COM | 14,500 | $3.2 million |
| Soleno Therapeutics Inc | COM | 68,490 | $2.3 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 20,400 | $1.5 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 5,886 | $495,425 |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 28,970 | $432,522 |

## Also on SpecStream

- [Artia Global Partners LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1937964/000193796426000008/0001937964-26-000008-index.htm)
- [Artia Global Partners LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/artia-global-partners-lp-322091)
- [Largest 13F filers in Florida](https://specstream.ai/data/institutional-holdings/state/florida)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Miami, Florida

- [Art schools in Miami, Florida](https://specstream.ai/data/businesses/art-schools/miami-florida-united-states)
- [Chicken restaurants in Miami, Florida](https://specstream.ai/data/businesses/chicken-restaurants/miami-florida-united-states)
- [Distribution companies in Miami, Florida](https://specstream.ai/data/businesses/distribution-companies/miami-florida-united-states)
- [Garage door companies in Miami, Florida](https://specstream.ai/data/businesses/garage-door-companies/miami-florida-united-states)
- [Italian restaurants in Miami, Florida](https://specstream.ai/data/businesses/italian-restaurants/miami-florida-united-states)
- [Music schools in Miami, Florida](https://specstream.ai/data/businesses/music-schools/miami-florida-united-states)
